n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, May 9th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Golden Arrow Resources Corp. (GARWF)

FutureMoneyTrends and Money and Markets reported earlier on Golden Arrow Resources Corp. (GARWF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Arrow Resources Corp. is an explorer and prospect generator headquartered in Vancouver, British Columbia. The Company’s emphasis is on identifying, acquiring, and advancing precious and base metal discoveries with the aim of defining first-rate deposits. Golden Arrow's main focus is on advancing its flagship Chinchillas Silver Project in Jujuy Province, Argentina. The Company is a member of the Grosso Group, a management company specialized in resource exploration. Golden Arrow Resources has exploration offices in Ciudad de Mendoza, Argentina. The Company lists on the OTCQB.

The Chinchillas Silver deposit will be developed into a satellite open-pit mine. The Chinchillas Silver Project features low capex (capital expenditure) and fast-tracked development utilizing infrastructure from the Pirquitas mine. It has a positive pre-feasibility study with strong economics as well as immediate production income from the Pirquitas mine operation.

Golden Arrow Resources’ other Argentina projects include the Antofalla Silver-Gold-Base Metal Project in Catamarca Province; and the Don Bosco Copper-Gold Project and the Caballos Copper-Gold Project, both in La Rioja Province.

Projects also include the Mogote Copper-Gold Project; the Pescado Gold Project; and the Frontera District - Potrerillos Gold-Silver Project. All of these are in San Juan Province.

Last week, Golden Arrow Resources announced that it is establishing a production work committee that will include very experienced mining engineer Mr. Alf Hills. Mr. Hills will monitor the production procedure to comply with the joint venture (JV) agreement conditions, corporate management responsibilities, and governance.

At first, Mr. Hills will be an advising consultant to Golden Arrow Resources. He will subsequently be appointed to represent Golden Arrow on the Board of the recently announced JV company, which will be structured to hold Golden Arrow's Chinchillas project and the Pirquitas mining and processing facilities of Silver Standard Resources Inc. (SSRI), both of which are in Jujuy Province. Upon closing, expected on or before May 31, 2017, the JV will hold Chinchillas and Pirquitas owned 75/25 by Silver Standard and Golden Arrow Resources.

In addition, last week, Golden Arrow Resources reported on the positive progress of the exploration program at the Antofalla silver-gold-base metal project in Catamarca Province, Argentina. The 8,760 hectare Antofalla project has strong geologic similarities to Golden Arrow’s flagship Chinchillas silver project. The Company sampled 281 g/t Silver, 0.5 percent lead over 3.35 meters from the new target at the Antofalla Silver-Gold-Base Metal Project.

Golden Arrow Resources Corp. (GARWF), closed Tuesday's trading session at $0.4421, up 0.48%, on 126,053 volume with 81 trades. The average volume for the last 60 days is 162,477 and the stock's 52-week low/high is $0.402/$1.30.

PHI Group, Inc. (PHIL)

SmarTrend Newsletters, FNNO Newsletters, AllPennyStocks, Breaking Bulls, OTCPicks, Stockpalooza, Canadian Microcap Report, PickPennyStocks, and Stockdigest Report reported on PHI Group, Inc. (PHIL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

PHI Group, Inc. concentrates on acquisitions and investments in natural resources, energy, agriculture, and special situations. The Company mainly involves in Mergers and Acquisitions (M&A) as a principal; investing in special situations; and providing advisory and consulting services to global clients. It provides M&A advisory services via its wholly-owned subsidiary, PHI Capital Holdings, Inc. Established in 1982, PHI Group lists on the OTCQB.

The Company’s business strategy includes building, acquiring, committing, and deploying valuable resources with distinct competitive advantages and acquiring, participating and competing in attractive businesses that have large, growing market potential. Its business strategy also includes designing and implementing strong management systems and providing points of exit for investors via capital appreciation or spin-offs of business units.

At present, PHI Group works closely with several private equity firms to boost inorganic growth through acquiring cash-flow positive companies that can add considerable revenues and bottom lines to PHI.  Moreover, these selective acquisitions will serve as platforms for entry into new markets with the potential for high growth.

The Company looks for special investment opportunities, which may command warranted, justifiably extraordinary profit margins because of product and/or service attributes. These may open up new domestic and global markets otherwise not available that are positioned for high growth.

In April, PHI Group announced that it created “Smartway International, Inc.,” (a Wyoming corporation), as a holding company for Smartway GmbH, a German company with advanced algorithms that provide competitive all-inclusive software and dynamic vehicle control systems for urban areas. Smartway GmbH’s business model is established on intelligent bundling of existing resources, all digital and automated bundling of bookings, and scalable door-to-door multi-services internationally.

Also, in April, PHI Group announced that it signed a Memorandum of Understanding (MOU) with Maxagro Group (Romania-based) with annual revenues of roughly EUR 30 million. The alliance’s intention is to develop an organic farming program in Timis County, Romania.

PHI Group announced recently that PHI Group Regional Center LLC filed an application with the United States Citizenship and Immigration Service (USCIS) for the PHI Group EB5 Regional Center in Florida. PHI’s intention is to raise $15 million and create 300 new full-time jobs through the PHI Group EB5 Regional Center during the first phase of its organic farming program and other business activities in the State of Florida. PHI has opened an escrow account to acquire a farm in Holmes County, Florida. This farm includes 408 acres of land, buildings, barns, fixtures, certain equipment, as well as water pumping rights for irrigation.

PHI Group, Inc. (PHIL), closed Tuesday's trading session at $0.0585, even for the day. The average volume for the last 60 days is 53,098 and the stock's 52-week low/high is $0.0461/$2.00.

Research Solutions, Inc. (RSSS)

Marketbeat and Wall Street Resources reported on Research Solutions, Inc. (RSSS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Research Solutions, Inc. is a pioneer in providing cloud-based solutions for scientific research. The Company is an innovator in cloud-based SaaS (Software-as-a-Service) research intelligence products and services for research-intensive organizations. Research Solutions has its wholly-owned subsidiary Reprints Desk, Inc. The Company’s cloud-based SaaS platform provides customers with on demand access to and augmented data from, tens of millions of scientific, medical, and technical (STM) documents. This is in addition to tens of millions of articles previously published.  Research Solutions is based in Encino, California.

Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Reprints Desk and Altmetric LLP earlier agreed to integrate Altmetric badges to scholarly content obtained through Reprints Desk's award-winning research retrieval platform Article Galaxy. Altmetric is a leading research metrics provider.

The Altmetric badges provide an at-a-glance visualization of the attention a particular journal article has received online from the mainstream and social media, public policy documents, blogs, Wikipedia and scholarly forums. This helps scientists in evaluating the reach and influence of research.

Last month, Research Solutions, and its wholly-owned subsidiary Reprints Desk announced the launch of a new version of the Company's award-winning Article Galaxy research platform. New features include full mobile responsiveness, design enhancements, an improved order history page, and the introduction of an ecosystem of gadgets - strong applications that allow for sophisticated data augmentation of content.

Also, in April, Research Solutions announced that subsidiary Reprints Desk signed separate reseller agreements with Ritme and Alfasoft to deliver new tools and services, which address the full spectrum of knowledge acquisition and information management requirements of researchers in scientific, technical and medical (STM) fields.

As part of the agreements, the new European resellers will expand Reprints Desk's market penetration in Western Europe and offer the Company's Article Galaxy SaaS research platform to European researchers and scientists, allowing for one-click access to scientific documents at the point of discovery and unlimited, data-driven research intelligence.

Last week, Research Solutions announced that it will hold a conference call on Monday, May 15, 2017 at 5:00 p.m. Eastern time to discuss its financial results for fiscal Q3 ended March 31, 2017. Financial results will be issued in a press release before the call.

Research Solutions, Inc. (RSSS), closed Tuesday's trading session at $0.96, down 0.01%, on 2,000 volume with 2 trades. The average volume for the last 60 days is 10,804 and the stock's 52-week low/high is $0.72/$1.2207.

Miramar Labs, Inc. (MRLB)

We are highlighting Miramar Labs, Inc. (MRLB) today, here at the QualityStocks Daily Newsletter.

Miramar Labs, Inc. is an international medical device company listed on the OTC Markets Group’s OTCQB. Fundamentally, the Company’s devotion is to bring the next generation energy modality to the field of dermatology. Its initial priority is advancing aesthetic treatments employing its proprietary miraWave™ technology platform. miraWave exploits the unique benefits of microwave energy to treat dermatologic conditions, including axillary sweat and hair of all colors. Miramar Labs has its corporate office in Santa Clara, California.

The miraWave technology delivers 5.8 GHz microwave energy. The energy is reflected at the dermal-fat junction. The energy becomes concentrated, creating a focal energy zone. Almost all sweat and odor glands reside at the dermal-fat interface. Focused heating is independent of skin thickness, hair color, or skin color

The Company’s first priority is the treatment of underarm sweat. The Company’s miraDry® procedure has an established safety and efficacy profile with greater than 70,000 patients treated globally. The miraDry® system and treatment uses precisely controlled microwave energy to provide a non-invasive solution to permanently eliminate axillary sweating for patients of all skin types.

The Company’s miraDry® received CE Mark approval in December 2013, following U.S. Food & Drug Administration (FDA) clearance in January of 2011. In July 2015, Miramar Labs announced its miraDry System received clearance from the FDA for the treatment of unwanted underarm hair and permanent reduction of underarm hair of all colors.

The miraDry System’s innovative miraWave technology delivers precisely focused energy at the dermal-fat junction. This is to safely heat and permanently destroy sweat and odor glands and hair follicles while protecting the sensitive underlying structures. miraDry is indicated for the treatment of primary axillary hyperhidrosis (excessive underarm sweating).

Miramar Labs subsequently introduced miraSmooth™ as the only procedure FDA cleared to provide the dual benefit of permanent underarm hair reduction and elimination of underarm sweat in one treatment.

This past March, Miramar Labs announced financial results for Q4 and full year ended December 31, 2016. Mr. Michael Kleine, Miramar Labs’ President and Chief Executive Officer, said, “We continued to achieve very strong momentum in our North America business, which grew 38 percent in 2016, driven by our efforts to increase awareness and adoption of our technology. We are also benefiting from the indication expansion for the miraDry® system, which now provides three distinct benefits to both physicians and patients with its ability to reduce axillary sweat, odor and hair. This unique value proposition for our customers and consumers, is a core driver of expanding our business and delivering on our growth objectives.”

Miramar Labs, Inc. (MRLB), closed Tuesday's trading session at $1.47, down 0.68%, on 25,400 volume with 14 trades. The average volume for the last 60 days is 3,741 and the stock's 52-week low/high is $1.00/$6.50.

DanDrit Biotech USA, Inc. (DDRT)

We are reporting on DanDrit Biotech USA, Inc. (DDRT), here at the QualityStocks Daily Newsletter.

DanDrit Biotech USA, Inc. is a clinical-stage company whose dedication is to developing the world’s first vaccine against colorectal cancer. The Company is concentrating on the clinical development of a dendritic cell vaccine for the treatment of colorectal cancer. DanDrit’s expertise in producing dendritic cells from a patient's blood is combined with conventional production methods with the goal of making new and advanced vaccines for cancer patients. DanDrit Biotech USA is headquartered in New York, New York. The Company’s shares trade on the OTC Bulletin Board.

The ability of dendritic cells to provoke a strong immune response is the foundation of the vaccine therapies under development at DanDrit Biotech USA. MelCancerVac® (MCV) is a new product by the Company for colorectal cancer. MVC uses a vaccination treatment program in addition to the customary treatment types of chemotherapy and surgery.

MelCancerVac® uses a patient’s own dendritic cells filled with tumor antigens from the lysate of a specifically selected melanoma cell line. MelCancerVac® has been tested in clinical trials for the treatment of two different types of cancer. One is colorectal cancer (CRC) and the other is non-small-cell lung cancer (NSCLC).

CRC clinical trials include Phase I at Gentofte Hospital, Denmark (Completed); Phase II at Gentofte Hospital, Denmark (Completed); and Phase II at the National Cancer Centre, Singapore (Completed). NSCLC clinical trials include Phase II at Herlev Hospital, Denmark (Completed).

Concerning DanDrit’s Vaccine Platform, the Company states that therapeutic dendritic cell-based vaccination of cancer patients represents one of the most promising non-toxic methods of treatment. The principal goal of the vaccination is to stimulate the patient’s own immune system to fight cancer cells.

The Company uses the patient’s own dendritic cells, taken from the blood and loaded with tumor antigens. The dendritic cells then undergo injection back into the cancer patient. There, surface expressed antigenic peptides are recognized by T lymphocytes. T lymphocytes are stimulated by the dendritic cells to proliferate and differentiate into effecter cells that target and destroy tumor cells specifically.

The Company’s therapeutic cancer vaccine is used either as separate treatment or complementary to other kinds of treatment such as surgery, chemotherapy, and radiotherapy. In addition, DanDrit Biotech USA has developed methods to produce tolerance-promoting dendritic cells for use in the treatment of autoimmune disease.

DanDrit Biotech USA has its Strategic Alliance strategy. It has built a strong pipeline of dendritic-cell-based cancer therapies, presently addressing 40 percent of all cancer-related deaths. The Company’s intention is to work with strategic partners to strengthen the in-house pipeline. DanDrit controls important technologies with relevance outside its core business area and these the Company says they may out-license or co-develop with appropriate partners.

DanDrit Biotech USA, Inc. (DDRT), closed Tuesday's trading session at $1.20, up 4.35%, on 270 volume with 2 trades. The average volume for the last 60 days is 5,560 and the stock's 52-week low/high is $0.70/$3.50.

graphic

The QualityStocks
Company Corner

graphic
graphic

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.04025, up 0.63%, on 3,296,095 volume with 220 trades. The stock’s average daily volume over the past 60 days is 6,238,908, and its 52-week low/high is $0.0062/$0.142.

Singlepoint, Inc. has signed a new agreement enabling the company to start onboarding 'high risk' merchant accounts. SinglePoint has committed much time and resources to finding solutions for businesses that are considered 'high risk'. Under this new agreement the company can now start onboarding these businesses. Once a business is approved they will be able to sell their products and services just as any other business does.

Additionally, CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announced publication today of an article that takes a look at SinglePoint's launch of its SingleSeed subsidiary as well as its near-term plans and upcoming catalysts.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Signs Reseller Agreement for High Risk Merchant Processing

SinglePoint Targets Cannabis Dispensaries with SingleSeed -- CFN Media

SinglePoint, Inc. Updates Shareholders on Initiatives to Strengthen Corporate Value

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.064, off by 6.84%, on 4,364,573 volume with 209 trades. The stock’s average daily volume over the past 60 days is 1,705,697, and its 52-week low/high is $0.0023/$0.0738.

Players Network, Inc. today announced the launch of a new, expanded, shareholder communications and investor relations campaign designed to broaden visibility to the investment community and provide added transparency to their stockholders by informing them of all current operations and future plans. The campaign was prompted by a significant increase in shareholder inquiries, the Company's desire for increased transparency for its stakeholders and the transition from developmental-stage holdings into operational. This interest is attributed to entering the marijuana industry through its holdings along with achieving multiple milestones and recent updates.

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.

WeedTV.com

WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

Player's Network, Inc. Launches Major Shareholder Communications Initiative

Player's Network, Inc. Announces Launch of Marijuana Accelerator Division

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.40, off by 4.76%, on 56,844 volume with 40 trades. The stock’s average daily volume over the past 60 days is 188,415 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. is expanding its existing cloud-based platform and has scheduled pilot tests of its beta module for sterilization processing in the operating room in mid to late Q2. With over 51 million surgeries performed annually in the U.S., ORHub's platform addresses a vast market of care providers looking for ways to save time and money through the surgical process.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub (ORHB) Enhances Leading Data Analytics Platform with Integration of Sterilization Process Module

ORHub (ORHB) Appoints New Chief Operating Officer to Facilitate Growth Strategies

Significant Milestone Helps ORHub (ORHB) Deliver Cost-cutting Insight to Health Care Providers

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.477, off by 9.26%, on 1,410 volume with 6 trades. The stock’s average daily volume over the past 60 days is 7,241, and its 52-week low/high is $1.33/$4.35.

Monaker Group, Inc. will participate at the Oppenheimer & Co. Emerging Growth Conference to be held at the InterContinental New York Barclay hotel in New York City, on Tuesday, May 16, 2017. Bill Kerby, Monaker Group CEO, and Richard Marshall, the company's director of corporate development, will be available for one-on-one meetings with investors throughout the day. Management will discuss the company's launch of Monaker Booking Engine (MBE), the first customizable, alternative lodging reservation system with instant booking of vacation homes, villas, chalets, apartments, condos and castles.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Group to Attend the Oppenheimer Emerging Growth Conference in New York City on May 16th

Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017

Monaker Group Appoints Robert Post to Board of Directors

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.15, up 4.55%, on 22,270 volume with 36 trades. The stock’s average daily volume over the past 60 days is 79,654 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com, Inc. Appoints Summer Yun as CEO of CBD Biotechnology Co., Ltd., Wholly-owned Foreign Entity

Consilium Global Research Issues Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Epic Stock Picks
(ATLT) +66.67%

2.

MarketClub Analysis
(CLNT) +66.67%

3.

StockMarketWatch
(LMFAW) +57.15%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251